A Study Comparing ex Vivo MRI Versus Radiography of Breast Specimens
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01869335|
Recruitment Status : Unknown
Verified May 2013 by Roberto Agresti, MD, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano.
Recruitment status was: Not yet recruiting
First Posted : June 5, 2013
Last Update Posted : June 5, 2013
|Condition or disease||Intervention/treatment||Phase|
|Breast Cancer||Device: radiography Device: MRI (magnetic resonance imaging)||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||260 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Randomized Study Comparing ex Vivo MRI Versus Radiography of Breast Specimens in Evaluating Tumor-free Margins After Surgical Resection of Breast Microcalcifications|
|Study Start Date :||May 2013|
|Estimated Primary Completion Date :||December 2014|
|Estimated Study Completion Date :||May 2015|
Active Comparator: radiography
Arm1: patients undergo mammographic localizations and radiography of the specimen after surgical resection.
Active Comparator: MRI (magnetic resonance imaging)
Arm2: patients undergo MRI localization and ex vivo MRI after surgical resection.
Device: MRI (magnetic resonance imaging)
- Diagnostic efficacy of Magnetic Resonance Imaging (MRI) versus radiography in evaluating tumor-free margins in breast cancer specimens [ Time Frame: 2 years ]Diagnostic efficacy will be evaluated by statistical analysis
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01869335
|Contact: Roberto Agresti, MD||+39 02 2390 ext firstname.lastname@example.org|
|Fondazione IRCCS Istituto Nazionale dei Tumori||Not yet recruiting|
|Milan, Italy, 20133|
|Contact: Roberto Agresti, MD +39 022390 ext 2168 email@example.com|
|Principal Investigator: Roberto Agresti, MD|